A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass
Michael S. Avidan, Jerrold H. Levy, Jens Scholz, Elise Delphin, Peter M.J. Rosseel, Michael B. Howie, Irwin Gratz, Charles R. Bush, Nikolaos Skubas, Gabriel S. Aldea, Michael Licina, Laura J. Bonfiglio, Daniel K. Kajdasz, Elizabeth Ott, George J. Despotis
Dive into the research topics of 'A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass'. Together they form a unique fingerprint.